LOWELL, Mass.--(BUSINESS WIRE)--Alere Analytics, an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced that Chief Medical Officer and Co-founder, Dr. Fauzia Khan will participate in an industry panel that spotlights how advanced analytics and population health management are driving the next generation of Accountable Care Organizations (ACOs) at the 2014 U.S. News and World Report Hospital of Tomorrow (HOT) Conference. The conference, which is being held at the Washington Hilton in Washington D.C. on October 6 - 8, will address critical and mounting challenges facing hospitals and health care systems today. During the conference, Alere Analytics will be showcasing the Company’s suite of hospital and provider solutions at booth #303.
In Dr. Khan’s panel discussion, she will discuss how population health management enables healthcare organizations to meet their operational, financial and clinical goals, by leveraging advanced analytics to identify critical gaps in care and streamline administrative costs. At the population-level, real-time analytics can assist hospitals, providers and ACOs to more effectively manage chronic conditions, reduce hospital admissions and readmissions, and ultimately may improve patient outcomes. She will further discuss that by incorporating both real-time clinical information and claims data, providers can obtain a comprehensive view of their entire population data landscape, and thus are able to identify those with the greatest noncompliance risk and the most actionable clinical opportunities for improvement.
Information About Alere Analytics’ Industry Panel
Conference: U.S. News & World Report Hospital of Tomorrow (HOT)
When and Where: Tuesday, October 7 at 8:45 AM at the Washington Hilton, Washington, D.C.
Track: The Next Generation of Accountable Care Organizations (ACOs)
Panelist: Dr. Fauzia Khan, Chief Medical Officer and Co-Founder, of Alere Analytics, Chair, Alere Inc. Medical Advisory Board
Panel Synopsis: As more hospitals, health care systems, medical groups and other providers create accountable care organizations, their potential to deliver on the promise of higher-quality care and better outcomes at a lower cost is starting to take shape. While it’s still too early to judge the long-term viability of ACOs, how these new collaborations are playing out can provide insight into their ultimate benefits and limitations. In this session, hospitals that have implemented ACOs, and a leading CMS expert, share their lessons learned in reconstituting care delivery and what steps are necessary to improve the model and spur more widespread adoption and success.
If you are interested in learning more about Alere Analytics and our hospital technology solutions, please visit our website at www.AlereAnalytics.com, as well as the NHSN reporting resource site provided by the Association for Professionals in Infection Control and Epidemiology (APIC). Alere Analytics offers a comprehensive suite of innovative hospital and provider solutions, which includes clinical surveillance, population health management, anticoagulation home monitoring, regulatory reporting, quality measures and infection control solutions.
About Alere Analytics
Alere Analytics, formerly DiagnosisOne, provides the healthcare industry with unparalleled analytics and clinical decision support tools based on a single platform. The company’s analytics and decision support solution leverages the world's largest library of evidence-based medical knowledge and integrates seamlessly with existing hospital and laboratory information systems. It delivers intelligent and actionable information that can help to improve patient care, fewer errors and better clinical outcomes. Alere Analytics’ customers include hospitals, healthcare providers, payers, EHR companies, systems integrators and government entities. Based in Lowell, Mass., Alere Analytics was formed as DiagnosisOne in 2005 by a team of physicians and healthcare IT professionals. In July 2012, DiagnosisOne joined Alere, a leading provider of near-patient diagnostics and health information solutions, and is now conducting business as Alere Analytics. For more information about the Company and its solutions, visit www.alereanalytics.com.
About Alere Inc.
Alere’s global leading rapid diagnostic products and services, as well as its new product development efforts, focus on infectious disease, cardiometabolic disease and toxicology. Alere is headquartered in Waltham, Massachusetts. For more information regarding Alere, please visit www.alere.com.